XML 173 R23.htm IDEA: XBRL DOCUMENT v3.25.2

Merger with Sesen Bio (Tables)

12 Months Ended

Dec. 31, 2024

Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]

Schedule of Net Assets Acquired in the Merger

The following table shows the net assets acquired in the Merger (in thousands):

​	​	​	​
​		March 7, 2023
Cash and cash equivalents	​	$	37,873
Marketable securities	​		44,588
Prepaid expenses and other assets	​		1,316
Restricted cash	​		30
Accounts payable and accrued expenses	​		(3,499)
Total net assets acquired	​		80,308
Less: Transaction costs	​		(8,264)
Total net assets acquired less transaction costs	​	$	72,044

X

- References

No definition available.

+ Details

Name:	us-gaap_BusinessCombinationAndAssetAcquisitionAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of asset acquired and liability assumed in business combination and recognized at acquisition date.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479907/805-20-50-2

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479907/805-20-50-1

+ Details

Name:	us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration